Steve Worland
CEO of eFFECTOR, a company targeting three distinct targets central to the eIF4F translation initiation complex
Best podcasts with Steve Worland
Ranked by the Snipd community
Apr 29, 2024 • 18min
Selective Translation Regulator Inhibitors: Depriving cancer of what it needs
Steve Worland, CEO of eFFECTOR, discusses Selective Translation Regulator Inhibitors (STRIs) targeting 3 key genes in cancer cells, the future of cancer treatments, and the importance of pharma collaborations in drug development.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
